Want to see AU:LGP full AI Analyst Report?
LGP Stock Chart & Stats
AU$0.10
<AU$0.01(1.67%)
At close: 4:00 PM EST
AU$0.10
<AU$0.01(1.67%)
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.15
Previous CloseN/A
Volume21.69K
Average Volume (3M)184.01K
Market Cap
AU$52.99M
Enterprise ValueAU$28.30M
Total Cash (Recent Filing)AU$1.42M
Total Debt (Recent Filing)AU$4.69M
Price to Earnings (P/E)―
Beta0.89
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding827,978,700
10 Day Avg. Volume233,691
30 Day Avg. Volume184,008
Financial Highlights & Ratios
PEG Ratio0.15
Price to Book (P/B)0.36
Price to Sales (P/S)0.70
P/FCF Ratio-37.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.15Price Target Upside50.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageConservative leverage gives LGP financial flexibility to fund operations, manage volatility and pursue growth without excessive interest or refinancing pressure. This strengthens resilience while the company works toward consistent profitability.
Long-term Revenue ScaleThe substantial multi-year increase in revenue indicates that LGP has built meaningful commercial scale in medicinal cannabis. A larger operating base can support broader distribution, product development and improved fixed-cost absorption over time.
Improving Cash BurnAlthough LGP is not yet self-funding, the sharp reduction in cash burn suggests progress in operating discipline and capital efficiency. Sustaining this improvement could reduce future dependence on external funding and preserve strategic flexibility.
Bears Say
Recent Revenue ContractionThe latest revenue pullback interrupts LGP’s longer-term growth trajectory and may indicate weaker demand, market access challenges or product-mix pressure. Continued contraction would limit operating leverage and make a return to sustainable profit more difficult.
Inconsistent ProfitabilityLosses and negative EBIT show that the core business has not yet produced dependable operating returns. Earnings volatility, including the divergence between net income and operating profit, reduces confidence in margin sustainability and long-term earnings quality.
Persistent Negative Free Cash FlowNear-breakeven operating cash flow is insufficient to cover investment requirements, leaving free cash flow negative. Unless cash generation improves consistently, LGP may need external capital, which could constrain growth or dilute existing shareholders.
Little Green Pharma Ltd. News
LGP FAQ
What was Little Green Pharma Ltd.’s price range in the past 12 months?
Little Green Pharma Ltd. lowest share price was AU$0.06 and its highest was AU$0.14 in the past 12 months.
What is Little Green Pharma Ltd.’s market cap?
Little Green Pharma Ltd.’s market cap is AU$52.99M.
When is Little Green Pharma Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Little Green Pharma Ltd.’s earnings last quarter?
Currently, no data Available
Is Little Green Pharma Ltd. overvalued?
According to Wall Street analysts Little Green Pharma Ltd.’s price is currently Undervalued.
Does Little Green Pharma Ltd. pay dividends?
Little Green Pharma Ltd. does not currently pay dividends.
What is Little Green Pharma Ltd.’s EPS estimate?
Little Green Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Little Green Pharma Ltd. have?
Little Green Pharma Ltd. has 827,978,700 shares outstanding.
What happened to Little Green Pharma Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Little Green Pharma Ltd.?
Currently, no hedge funds are holding shares in AU:LGP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Little Green Pharma Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.15 (50.00% Upside)
AU$0.15 (50.00% Upside)
Blogger Sentiment
Bullish
AU:LGP Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.76%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.46%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Little Green Pharma Ltd.
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
LGP Stock 12 Month Forecast
Average Price Target
AU$0.15
▲(50.00% Upside)
Technical Analysis
Elixinol Wellness
―
Cann Group
―
Althea Group Holdings Ltd.
―
Cronos Australia Ltd.
―